Company

Hims & Hers Health

Direct-to-consumer telehealth platform offering prescription medications and wellness products including compounded GLP-1 drugs

Healthcare & Biotech

People

Andrew Dudumfounder, ceo

News

Interviews (2)

TJ Parker: Hims' compounded GLP-1 pill is a 'financial hail Mary' with no evidence it works — and Trump Rx is the real deal

Hims & Hers CEO Andrew Dudum on telehealth's next act: personalized diagnostics, compounding, and $2B+ revenue

News (3)

Hims & Hers stock crashes 32% after Novo Nordisk terminates partnership over alleged GLP-1 knockoff sales

FDA moves to end Ozempic knockoffs, but Hims & Hers says it will keep selling compounded versions

Hims & Hers Super Bowl ad for compounded semaglutide ignites debate over IP, patient safety, and the GLP-1 gray market